失眠治疗对退伍军人治疗酒精使用障碍的负面情绪的影响
Mary Beth Miller1, Ryan W Carpenter2, Melissa Nance2
1University of Missouri, Columbia, Missouri, USA.
Alcohol, clinical & experimental research
|October 28, 2024
概括
治疗酒精使用障碍 (AUD) 患者的失眠症状可能会减少负面情绪,这反过来会降低酒精渴望和大量饮酒频率. 这突出了一个关键机制,将睡眠问题与与酒精有关的问题联系起来.
科学领域:
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
- 成研究 研究成研究
背景情况:
- 失眠症状在酒精使用障碍 (AUD) 中很常见,但根本机制尚未完全理解.
- 以前的研究表明,对失眠的认知行为疗法 (CBT-I) 通过改善失眠严重程度来减少与酒精有关的问题.
- 这项研究调查了负面情绪作为在AUD失眠和酒精之间潜在的调解者.
研究的目的:
- 检查负面情绪是否调解了减少失眠症状和改善与酒精有关的结果之间的关系.
- 测试CBT-I改善负面情绪,从而减少酒精渴望和重度饮酒的假设.
主要方法:
- 一项临床试验的二次分析,涉及67名AUD和失眠障碍的退伍军人.
- 参与者被随机分配到CBT-I或睡眠卫生控制组.
- 负面情绪被评估使用一个潜在的指标从五个验证的措施;酒精结果包括渴望,重度饮酒,和问题.
主要成果:
- 与对照组相比,对失眠的认知行为疗法 (CBT-I) 并没有显著改善负面情绪.
- 然而,在两组中,失眠症状的减少与负面情绪的同时减少有关.
- 减少负面情绪预测了更低的酒精渴望和减少重度饮酒频率.
结论:
- 负面情绪可能成为关键机制,将失眠症状与AUD患者的酒精相关结果联系起来.
- 针对失眠的干预措施可能通过减少负面情绪来间接改善酒精使用.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
154
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
9.7K
相关概念视频
CNS Depressants: Alcohol and Nicotine
177
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
177
Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79
Substance Use Disorders Affecting Sleep
160
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
160
CNS Depressants: Barbiturates and Benzodiazepines
228
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
228
Depressants
101
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
101
